Targeting angiogenesis with oral agents.
Besse
B
B
Institut Gustave Roussy, Department of Medicine, Villejuif, France.
Armand
J-P
JP
Soria
J-C
JC
D000284:Administration, Oral; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000517:prevention & control
D020533:Angiogenesis Inhibitors